Evercore ISI analyst Robert Ottenstein maintained a Buy rating on Colgate-Palmolive (CL – Research Report) yesterday and set a price target of ...

A near-230 year sold company, Colgate-Palmolive continues to transform to meet the demands of the changing CPG markets.

Piper Sandler analyst Korinne Wolfmeyer maintained a Buy rating on Colgate-Palmolive (CL – Research Report) today and set a price target of ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Colgate-Palmolive (NYSE:CL) and its peers.

Colgate-Palmolive’s shares (currently trading at $87.88) have posted a disappointing 15.1% loss, well below the S&P 500’s 8.9 ...

Colgate chairman, president and CEO Noel Wallace described Prime100 as “a high-growth, profitable, fresh dog-food asset”.

Shares of Colgate-Palmolive rose 0.4% in after-hours trading on Tuesday as the company agreed to buy Care TopCo Pty Ltd, ...

Van ECK Associates Corp cut its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 96.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,466 shares of ...

As part of its growth strategy, which includes investing in faster-growing product segments adjacent to its core categories, Colgate-Palmolive Company ...

Colgate-Palmolive (India) Ltd is sharply focusing on growing consumption and driving premiumisation in the oral care segment.

Reliance Securities Head of Research Vikas Jain and Prabhudas Lilladher Technical Research Vice President Vaishali Parekh ...